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Abstract
Aims: To isolate, characterize and select phages as potential biocontrol agents 
of enterohemorrhagic and Shiga toxin-producing Escherichia coli (EHEC and 
STEC) in cattle.
Methods and Results: Sixteen STEC and EHEC coliphages were isolated from 
bovine minced meat and stool samples and characterized with respect to their 
host range against STEC, EHEC and other Gram-negative pathogens; their 
morphology by electron microscopy; the presence of the stxl, stx2 and cl genes 
by means of PCR; RAPD and rep-PCR profiles; plaque formation; and acid 
resistance. Six isolates belonged to the Myoviridae and 10 to the Podoviridae 
families. The phages negative for six and cl that formed large, well-defined 
plaques were all isolated using EHEC O157:H7 as host. Among them, only 
CA911 was a myophage and, together with CA933P, had the broadest host 
range for STEC and EHEC; the latter phage also infected Shigella and 
Pseudomonas. Isolates CA911, MFA933P and MFA45D differed in particle 
morphology and amplification patterns by RAPD and rep-PCR and showed the 
highest acidity tolerance.
Conclusions: Myophage CA911 and podophages CA933P, MFA933P and 
MFA45D were chosen as the best candidates for biocontrol of STEC and EHEC 
in cattle.
Significance and Impact of the Study: This work employs steps for a rational 
selection and characterization of bacteriophages as therapeutic agents. This 
report constitutes the first documentation of STEC and EHEC phages isolated 
in Argentina and proposes for the first time the use of rep-PCR as a comple­
ment of RAPD on DNA fingerprinting of phages.
Introduction
Since the discovery of bacteriophages, the use of specific 
bacterial pathogen phages in the treatment of infectious 
diseases has been a highly attractive proposition. None­
theless, the appearance of antibiotics during the 1940s 
caused that approach to be essentially abandoned for dec­
ades in the Western countries (Summers 2001; Wang 
et al. 2006). Nowadays, however, an increasing number of 
antibiotic-resistant bacterial pathogens have revived the 
interest in phage therapy as a relevant biocontrol strategy. 
Phages selected as biocontrol agents should be highly 
infective on a wide variety of strains of the target patho­
gen (Brussow 2005; Denou et al. 2009; Donlan 2009), 
they must furthermore be obligate lytic infectants (and 
thus unable to recombine with the bacterial chromo­
some), and they should be devoid of virulence factors or 
antibiotic resistance genes that could become incorpo­
rated into the host bacterial genome (Matsuzaki et al. 
2005). Finally, the success of the treatment depends on 
choosing phages with the most suitable characteristics for 
the desired application. For example, when used in vivo, 
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they should be innocuous with respect to the commensal 
bacteria, and in oral applications they would have to 
tolerate gastric passage so as to maintain a sufficient 
concentration at the pathogen’s location to enable 
infection and lysis (Tanji et al. 2005; Callaway et al. 2008; 
Denou et al. 2009).
Previous authors have proposed phage therapy in cattle 
as a possible prophylactic method against the O157:H7- 
Shiga toxin-producing Escherichia coli (STEC) (Johnson 
et al. 2008). Shiga toxins are endotoxins encoded by tem­
perate lamboid phages (six-phages) of STEC (Brussow 
et al. 2004; Robinson et al. 2006). The enterohemorrhagic 
E. coli (EEIEC) is a subgroup among the STEC able to 
attach to the human intestinal wall and produce an 
effacing lesion by a type III secretion system. EHEC is 
considered the principal cause of haemolytic-uremic 
syndrome (HUS) (Rivero et al. 2004; Johnson and Taylor 
2008). Although the STEC serotype most frequently 
isolated from persons with diarrhoea is O157:H7; other 
serotypes - such as O26:H11, O103:H2, O111:NM and 
O145:NM - have also been linked to foodborne disease 
outbreaks worldwide (Allerberger et al. 2003; Meichtri 
et al. 2004; Wickham et al. 2006).
Argentina is among the countries with the greatest inci­
dence of HUS in the world (Rivero et al. 2004; Rivas 
et al. 2008), so that the establishment of precautionary 
measures to avoid the spread of this pathogen constitutes 
a major public health concern in this country. STEC and 
EHEC are innocuous to ruminants and are transient 
members of their gastrointestinal flora. Cattle are the 
main reservoir of these bacterial pathogens (Nastasijevic 
et al. 2008), and faecal contamination of meat during 
slaughter is the most common route for transmission to 
human beings (Kudva et al. 1999; Chase-Topping et al. 
2008). Thus, elimination of STEC and EHEC from the 
bovine gastrointestinal tracts before the butchering would 
constitute the first barrier needed to prevent the intro­
duction of these bacteria into the food chain.
The aim of this work was therefore to isolate, charac­
terize, and select phages as potential biocontrol agents of 
STEC and EHEC for oral administration to bovines. The 
sources used for phage isolation were bovine minced 
meat and bovine faecal samples to look for phages whose 
natural environment was already the bovine intestine, and 
pork sausage, as this meat has also been reported to be 
contaminated with STEC and EHEC (Smith et al. 1991; 
Dontorou et al. 2003). Phage isolates that failed to infect 
nonpathogenic E. coli were further characterized with 
respect to their morphology and genomic-amplification 
patterns. Selection was performed by considering as best 
candidates those phages with a wide spectrum of STEC- 
and EHEC-host serotypes that were also lacking stxl, stx2, 
and cl gene amplification by PCR, because, for one, the 
gene cl encodes a protein that represses transcription 
from the promoters of the lytic cycle genes on bacterio­
phage Lambda and in this way maintains the lysogenic 
state (Oppenheim et al. 2005; Brussow 2006). This gene is 
present in the 933W prophage of the EHEC strain EDL 
933 that also carries the stx2 gene (Perna et al. 2001). 
Finally, large plaque size formation - as a measure of the 
ability of phages to spread in the intestinal mucosa of 
ruminants - and acid resistance were also considered as 
desirable characteristics of phages chosen for use in cattle 
phage therapy.
Materials and Methods
Bacterial strains
Phage isolation and host range determination were 
performed with strains EDL 933 (ATCC 700927) of 
EHEC, the nonpathogenic E. coli WG5 (ISO 10705- 
2:1999) and ATCC 25922, plus the additional STEC, 
EHEC, and pathogenic isolates listed in Table 1.
Phage isolation
The isolation of phages was attempted from two commer­
cial minced meats, one pork sausage, and two bovine 
faecal samples, each collected from a different farm.
For faecal coliphage isolation, 10 g of each sample was 
mixed with 90 ml of E. coli broth modified with 
0 02 g I-1 of novobiocin (mEC+n, Merck, Darmstadt, 
Germany) and homogenized in a model 400 Stomacher 
(Seward Medical, London, UK) for 2 min at maximum 
speed. For the minced meat and sausage samples, 10 g 
was mixed with 90 ml of SM buffer [100 mmol I-1 NaCl, 
8 mmol I-1 MgSO4.7H2O, 50 mmol I-1 Tris-HCl (pH 
7-5), gelatin 2% (w/v)] and homogenized in the
Stomacher™ for 10 min at full speed before addition of 
10 ml of concentrated mEC+n (10X) to the mixture.
In both isolations, the particulate material was removed 
by centrifugation at 4000 g for 15 min. The supernatants 
were poured into sterile flasks, CaCl2 was added to a final 
concentration of 10 mmol I-1, and enrichment was begun 
by adding a cocktail of nine isolates of EHEC and STEC - 
300 ¡A of an overnight culture of each - as hosts, with 
these strains being highlighted in boldface in Table 1; 4 
with the serotype O157:H7; four non-O157 clinical isolates 
with serotypes O111:NM, O113:H21, O103:H2 and 
O145:H25; and one foodborne isolate of serotype 
O26:H11. The samples were then incubated overnight at 
37°C. After addition of chloroform to a final concentration 
of 4% (v/v), the enrichment was left for 30 min at room 
temperature and finally centrifuged at 4000 g for 15 min. 
This supernatant constitutes the first stage of enrichment.
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Table 1 Bacterial isolates
Organism Serotype Isolate number Source
EHEC/STEC 0157:H7 933, 69160, 68911, 71945,
474, 476, 537/448 466
1
STEC O103:H2 646/03 118/05 2
STEC 0113:H21 870/02 889/06 370/02 2
STEC O145:NM 002/02 1210/06 2
STEC O26:H11 CIDCA1 395/06 2
STEC 0111 :NM 67/03 207/02 534/05 2
STEC 0161 :H2 154 2
STEC O8:H19 763/02 215/06 209/03 2
STEC O22:H16 412/03 238/04 2
STEC O146:H28 656/04 2
STEC 015:H27 189/01 356/02 2
STEC 013:H6 654/04 2
STEC O145:H25 14/00 485/03 2
STEC O20:H19 805/03 32/05 537/04 2
STEC O174:H28 257/03 439/04 2
STEC ONT:H12 456 1
EIEC - 202 1
Shigella flexneri 2 48 1
Sh. flexneri 3 2013 2019 1
Shigella sonnei - 47-5035 1-3
Proteus spp. - 6011 3
Citrobacter freundii - 6293 3
Morganella morganii - 364 3
Salmonella spp. - 7452 3
Klebsiella pneumoniae - 4482, 4336 3
Escherichia cloacae - 6615, 6303 3
Serratia marescens - 6606 3
Klebsiella spp. - 6496 3
Acinetobacter spp. - 4581 3
Pseudomonas aeruginosa - - 3
EHEC, enterohemorrhagic E. coli; STEC, Shiga toxin-producing E. coli; EIEC, enteroinvasive 
E. coli.
The bacterial isolates in bold were used for phage isolation from the following source: 
1 - Hospital de Ninos 'Sor Maria Ludovica’ La Plata, Buenos Aires, Argentina. 2 - Administración 
Nacional de Laboratorios e Institutos de Salud (A.N.L.I.S.) 'Dr. Carlos G.Malbran', Ciudad 
autonoma de Buenos Aires, Argentina. 3 - Hospital de Pediatria 'Prof. Dr. Juan P. Garrahan’, 
Ciudad autonoma de Buenos Aires, Argentina.
The presence of phages was screened by a spot test of 
serial dilutions of this initial enrichment mixture onto 
each individual strain of host bacterium used for phage 
propagation after the addition of 0 2 ml of an overnight 
culture of that host to 5 ml of molten soft tryptic-soy 
(TS; Biokar Diagnostics, Allone, France) agar (0 6% [w/v] 
agar-agar).
A second enrichment was performed with each indivi­
dual host strain where lysis plaques were detected: 0 5 ml 
of an overnight bacterial culture of that host were added 
to 5 ml of TS broth along with 01 ml of the first 
enrichment supernatant; CaCl2 was added to a final con­
centration of 10 mmol I-1, and the mixture was incubated 
for 24 h at 37°C.
To isolate and purify phages from each second enrich­
ment, individual plaques, obtained by the double-agar­
layer method with the enrichment mixture and fresh host 
bacterium, were picked and placed in 5 ml of TS broth; 
0 2 ml of an overnight culture of the host strain was 
added; and the suspension was incubated at 37°C until 
complete lysis of the culture. The resulting lysate was seri­
ally diluted and seeded onto a fresh layer of agar medium 
along with a suspension of fresh host bacteria for a second 
plaque isolation by the double-agar-layer method. A total 
of three such enrichments were performed. The isolated 
phages were finally filtered through a 0-22-//m membrane 
and kept at room temperature for further assays.
Host range
The susceptibility to each phage of E. coli strains EDL 933, 
WG5 and ATCC 25922, along with the Gram-negative 
© 2010 The Authors
Journal compilation © 2010 The Society for Applied Microbiology, Journal of Applied Microbiology 109 (2010) 873-887 875
Selection of coliphages as biocontrol agents C. Dini and P.J. de Urraza
isolates listed in Table 1, was tested by a spot assay. 
Briefly, molten soft TS agar (5 ml) was mixed with 0 3 ml 
of an overnight host bacterium culture grown in TS broth 
supplemented with 10 mmol I-1 of CaCI? and then spread 
out on TS-agar plates. When the plates were dry, 10 ¿il 
drops of the filtered phage suspensions containing from 
5 X 108 to 109 PFU ml-1 were spotted onto the bacterial 
lawn. Plates were incubated at 37°C for 20 h and then 
examined for lysis zones (Muniesa et al. 2003b).
Electron microscopy of bacteriophages
The morphology of phages was examined by transmission 
electron microscopy. A 10 ¡A drop of each filtered isolated 
phage was negatively stained with 2% (w/v) phospho­
tungstic acid and applied to the surface of a copper grid 
and examined in a JEOL 1200 EX II transmission electron 
microscope (Facultad de Veterinaria, UNLP, Argentina or 
INTA Castelar, Argentina). Phages were classified accord­
ing to their respective families as stated in the guidelines 
of the International Committee on Taxonomy of Viruses 
(2000).
DNA isolation and quantification
DNA extraction was performed by the protocol described 
by Sambrook and Russell (2001). Of each phage lysate, 
1 ml was incubated with 1 U of DNAase 1 (Invitrogen, 
Buenos Aires, Argentina) and 1 U of RNAase A (Bio­
dynamics, Buenos Aires, Argentina) for 30 min at 37°C. 
After degradation of phage protein coats with EDTA (pH 
8), proteinase K, and sodium dodecylsulfate, the proteins 
were removed by phenol-chloroform extraction, and the 
phage DNA was isopropanol-precipitated, washed with 
70% (v/v) aqueous ethanol, and resuspended in 50 ¡A of 
Tris-EDTA buffer (pH 7 6).
Extraction of bacterial DNA from the EHEC strain 
EDL 933 was performed with a commercial kit (Illustra™ 
bacterial genomic prep mini spin, GE Healthcare, Little 
Chalfont, UK).
All phage and bacterial DNAs were quantified by optical 
density at 260/280 nm with a Model ND-1000 spectro­
photometer (NanoDrop Technologies, Thermo Fisher 
Scientific Inc., Wilmington, Delaware, USA) and diluted in 
Tris-EDTA buffer to 30 ¿ig ml-1 for PCR assays.
RAPD and rep-PCR
For RAPD fingerprinting, the primers RAPD6, RAPD9, 
and RAPD10 (Madueno et al. 2009) were used. The 
amplification was performed by means of a StrataGene 
Gradient Cycler™ under the following conditions: 4 low 
stringency cycles of 5 min at 94°C, 5 min at 40°C, and 
5 min at 72°C; 30 high-stringency cycles of 1 min at 
94°C, 1 min at 55°C, and 1 min at 70°C; and a final 
extension of 10 min at 72°C. The reaction products were 
stored at 4°C until needed.
For rep-PCR, the primers Ericlr and Boxair (Versalovic 
et al. 1994) were used. The amplification was performed 
by means of the StrataGene Gradient Cycler™ under the 
following conditions: 1 cycle at 94°C for 2 min; 35 cycles 
at 94°C for 30 s, at 40°C for 45 s, and at 72°C for 2 min; 
and one final cycle at 72°C for 3 min. The reaction 
products were stored at 4°C until needed.
Both the RAPD and rep-PCRs were performed in a 
20-//I volume containing 2 ¡A of (10X) PCR buffer 
(200 mmol I-1 Tris-HCl, 500 mmol I-1 KC1, pH 8 3; 
Invitrogen), 2 ¿(1 of 2 mmol I-1 dNTPs, 1 U of Taq DNA 
polymerase (Invitrogen), 30 ng of DNA template, 15 pmol 
of primer, with the final volume adjusted with DNAase- 
free miliQ water. The total volume of each PCR product 
was analysed by 1% (w/v) agarose gel electrophoresis and 
the bands visualized by ethidium bromide staining.
Screening for stxl, stx2, and cl genes by PCR
Screening for the presence of the stxl and stx2 genes was 
performed by a multiplex PCR according to a standard 
protocol (Rivas et al. 2007) with the primers designed by 
Pollard et al. (1990). Stated in brief, the amplification 
conditions were 1 cycle at 94°C for 5 min; 30 cycles at 
94°C for 30 s, 58°C for 30 s, and 72°C for 30 s; and 1 
final cycle at 72°C for 2 min.
Detection of the cl gene was performed by using the 
upper primer 5'-CATCTGCAGTTCTCCATCTCTGTCA- 
TAG-3' and the lower primer 5'-CGGAATTCGTCTTG- 
ATGAACATGGTAG-3'.
Both of these primers were synthesized by Invitrogen 
Argentina and designed on the basis of the sequence for 
cl obtained from the genome sequence of the entero­
bacterium phage 933W (GenBank, accession number 
NC_000924). The amplification conditions were as 
follows: 1 cycle at 94°C for 2 min; 30 cycles at 94°C for 
45 s, 53°C for 45 s, and 72°C for 45 s; and a final cycle at 
72°C for 1 min.
Both the stx and cl PCRs were performed in a 20-//1 
volume as described for RAPD and rep-PCR. PCR prod­
ucts were analysed by 15% (w/v) agarose gel electropho­
resis. In both instances, the PCR bands obtained with the 
EDL 933 DNA template were used as positive controls.
Plaque morphology
The analysis of plaque morphology - obtained in Luria 
Bertrani (LB), TS, and Nutrient (N) agar with and with­
out the addition of 10 mmol I-1 CaCl2 - was performed 
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by adding 0 3 ml of an exponentially growing culture 
(ODm nm, c- 0 3) of the EHEC strain used as host for 
phage isolation plus 01 ml of phage lysate diluted in SM 
buffer to IO2 PFU ml-1 to 5 ml of molten soft agar in 
each medium. When CaCl2 was to be present, 50 ¡A of a 
filtered 1 mol I-1 solution was added. The mixture was 
poured onto the corresponding agar medium plates and 
incubated for 24 h at 37°C. After incubation, the plaque 
sizes were analysed, and the plates kept at room tempera­
ture for another 72 h to determine whether the plaque 
morphology and/or size changed with time.
Resistance of the phages to acidity
Suspensions of each phage were exposed to a range of 
pEI values from 1 to 7 over a 16-h period then checked 
for survival. A given phage suspension (01 ml, 
109 PFU mF _1) was added to 0 9 ml of saline adjusted to 
each specific pEI with FIC1 (15 mol I-1), and the mixture 
incubated at 37°C for 16 h (Flazem 2002). A mixture of 
01 ml of phage suspension and 0 9 ml of normal saline 
(pH 7-2) was also incubated at 37°C for 16 h as a control. 
After incubation, 01 ml of the phage suspension, previ­
ously neutralized with NaOFI (1 mol I-1), was serially 
diluted 10-fold, mixed with 0 2 ml of a suspension of the 
host bacterium (IO9 CFU ml-1), and incubated for 
20 min at room temperature. The mixture was then 
added to 5 ml of molten soft LB agar (06% [w/v] agar- 
agar) and spread over a plate of LB agar. Titres of the 
surviving phages were determined by plating 10-fold dilu­
tions according to the soft agar-overlay method.
Statistical analysis
Comparisons of the mean plaque sizes and of the mean 
titres after incubation at pH 4 were evaluated by the one­
way analysis of variance (anova) with a significance level 
of 5% (P < 0 05) followed by Fisher’s least significant 
difference test at a P < 0 05.
Results
Phage isolation and host range
A total of 20 phage isolates was obtained and designated 
according to their original source (C for minced meat, 
MF for faecal samples and CH for pork sausage plus A, 
B, or C for sample identification and a final number indi­
cating the bacterial strain used as host for phage isola­
tion). For phages isolated from the same agar plate, a 
letter indicating a characteristic of its plaque morphology 
comes at the end of the name. For example, phage 
CA933D was isolated from meat sample A with EHEC
Table 2 Isolated phages
Phage isolate Propagation host
CHA60, CB60P, CB60H,
MFA60D, MFA60N
CA911, MFA911
MFA45D, MFA45N
CA933N, CA933P, CA933D,
MFA933H, MFA933P
CBO103, CCO103
CBO113, CCO113
CCO26, MFCO26
Clinical isolate 69160 <0157:H7)
Clinical isolate 68911 <0157:H7)
Clinical isolate 71945 <0157:1-17)
Clinical isolate 933 <01 57:H7)
Clinical isolate 646/03 <0103:H2)
Clinical isolate 870/02 <0113:H21)
Food-borne isolate CIDCA1 (026:1-111)
933 as host and formed diffuse plaques. The phages 
isolated are listed in Table 2.
For fast screening of the phages that targeted non- 
pathogenic E. coli, strains WG5 and ATCC 25922 were 
first tested as hosts to discard those phages as possible 
biocontrol agents for phage therapy in cattle as phages 
infecting nonpathogenic E. coli could perturb the bovine 
commensal flora.
None of the isolates infected E. coli ATCC 25922; but the 
isolates CHA60, CCO26, MFCO26 and MFA911 did infect 
WG5 and were thus excluded. The other phage isolates, 
after testing against all the Gram-negative pathogens listed 
in Table 1, gave the host range results summarized in 
Table 3. None of the remaining phage isolates were able to 
infect the STEC serotypes O111:NM, O145:NM, O8:H19, 
O161:H2, O20:H19, O15:H27, O146:H28, or other Gram­
negative pathogens (except for Pseudomonas and Shigella). 
Thus, those bacterial test strains are omitted in Table 3.
The host range among the phages isolated with EHEC 
O157:H7 as host (0157 phages) - except for CB60P, 
CA911, and CA933P - is almost identical, is quite narrow 
and differs only in EDL 933 sensitivity. The host ranges of 
non-O157 phages are furthermore similar to each other 
but include the serotypes O26:H11 and O113:H21, which 
are not infected by 0157 phages. The widest host range for 
STEC and EHEC was observed for phage CA911 (Table 3). 
The isolate CA933P was the only 0157 phage able to infect 
serotype O13:H6 but was also the only one capable of 
infecting Shigella flexneri 2, Sh. flexneri 3.
Of all the other Gram-negative pathogens tested, other 
than Shigella, only Pseudomonas aeruginosa was sensitive 
to any of the phages, and most of the latter gave clear lysis 
zones when spotted onto this strain (Table 3). Phages 
CBO103, CBO113, CCO103, CCO113 and CB60P exhib­
ited extremely turbid lysis zones when inoculated into 
most of their bacterial hosts (indicated as T in Table 3).
Bacteriophage ultrastructure
Transmission electron micrographs of the different 
morphologies of the phage isolates and their approximate
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Phage Size (nm)
CBO103 176
CCO103 166
(g)
Figure 1 Bacteriophage electron microscopy, (a)-(h) show the 
different morphologies and particle length observed for each group of 
isolated bacteriophages.
particle sizes are shown in Fig. 1. All of the isolated 
phages were classified into two morphological families of 
tailed phages of the order Caudovirales: 10 isolates 
belonged to the Podoviridae family (head with icosahe- 
dral symmetry, straight and short noncontractile tail) 
morphotype Cl (isometric head) (Ackermann 2001) with 
four different morphologies (Fig. la-d) and the other six 
to the Myoviridae family (contractile sheath and icosahe- 
dral head) morphotype Al (isometric head) (Ackermann 
2001) with four different morphologies (Fig. le-h). All 
phages isolated from non-O157:H7 hosts belonged to the 
Myoviridae family.
Despite being isolated from different sources, the podo- 
phages infecting the O157:H7 strain 933 as host shared
the same morphology, but with different particle sizes, as 
observed in Fig. la.
Screening of cl, stxl and stx2 genes by PCR
The amplification of stxl and stx2 was tested as these 
genes encode the virulence factors most frequently found 
among phages infecting STEC and EHEC (Muniesa and 
Jofre 1998, 2004; Muniesa et al. 2004b), as Shiga toxins 
are prophage encoded in the genome of these bacterial 
pathogens. A PCR amplification of the cl gene was also 
tested as evidence of the presence of phages capable of 
recombining with the host genome.
Myophage CB60P and podophage MFA60N, both 
isolated with 0157:147 strain 69160 as host, showed 
amplification of stx2. The Myoviridae phages CCO103 
and CBO103, both isolated from the 0103:142 host strain 
646/03, were positive for stxl. Only the non-O157 phages 
CBO103 and CCO113 were positive for cl, giving amplifi­
cation of the 511-bp product expected according to the 
position of the internal primers on the cl gene of phage 
933W (Table 4).
RAPD and REP-PCR profiles
Figure 2 shows the different patterns obtained by RAPD 
with the primers RAPD6, RAPD9, and RAPD10, and 
those produced by rep-PCR with primers BOXAIR and 
ERIC1R, while Table 4 lists the profiles corresponding to 
each phage. The phages were grouped according to the 
patterns arising from the different primers used. The 
members of group I are 0157 phages whose set of
Table 4 Results of phages PCR characterization
Group Phage Stx C1 RAPD6 RAPD9 RAPD10 ERIC 1R BOXA1R Family
CB60P Stx2+ - F C F D B M
CA911 - - - A G B B M
MFA45N - - A B A A C P
MFA45D - - B B B A A P
MFA60D Stx2+ - C A C B B P
II MFA60N Stx2+ - G B D C C P
CB60H - - G B D C A P
MFA933H - - G D D c F P
MFA933P - - G B D c F P
CA933N - - G D D c F P
CA933P - - G B D c F P
CA933D - - G B D c F P
lil CCO113 - + E F E E E M
CBO113 - - D E E F D M
CBO103 Stx1 + + - F E E D M
CCO103 Stx1 + - E - E E - M
Results of PCR specific for stx and cl and the profiles obtained by RAPD and rep-PCR shown in Fig. 2. No amplification is represented by (-). 
Family (M) Myoviridae, (P) Podoviridae. Phages highlighted in grey have all the same morphology and differ only in RAPD9 profiles.
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RAPD6
A B C D * E * F G
RAPD9
A B * C D E F *
RAPD10
A B C D E * F G *
BOXA 1R
A B C D * EF
ERIC1R
A B C * D E F*
Figure 2 RAPD and rep-PCR profiles. Shown are the different RAPD and rep-PCR profiles, (a)—(h) correspond to the profiles obtained with each 
primer (Table 4) and * corresponds to the 100-bp ladder (Invitrogen).
profiles have either poor or no similarity to each other or 
to those of members of the other groups. Within this 
group, phage CB60P in particular has RAPD and ERIC1R 
profiles not only different from those of the other 0157 
phages but also unique among the profiles obtained from 
all the tested isolates. Members of group II are 0157 
phages that all produce identical amplification profiles 
with the primers RAPD6, RAPD10 and ERIC1R. 
Within this group, the phages isolated with strain 933 
(highlighted in grey in Table 4) have identical BOXAIR 
profiles as well, with some of the members differing in 
only the RAPD9 profiles. This result agrees with the simi­
larities observed with respect to morphology (Fig. la). 
Group III contains the phages isolated from the serotypes 
O103:H2 and O113:H21 (non-O157 phages). Their pro­
files are similar to each other, but all differ from those of 
the 0157 phages. This distinction also pertains with 
respect to host range, as this group differs clearly from 
the phages of groups I and II with respect to the sero­
types targeted. This group classification is furthermore 
reflected in the profiles obtained with the primer 
RAPD 10, as groups II and III each have a characteristic 
RAPD 10 profile, while group I has a completely different 
set of patterns.
Plaque morphology
Besides being exclusively lytic, the phages used in patho­
gen therapy should be highly effective as bactericidal 
agents. Abedon and co-workers have proposed that 
phage plaque growth in semisolid media be considered 
an approximation of phage population kinetics in natu­
ral spatially structured environments such as animal 
mucosal tissues (Abedon and Culler 2007a; Abedon 
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and Yin 2008), so that the formation of larger plaques 
in vitro (with host, bacterial growth conditions, and agar 
thickness remaining constant) could be compared to the 
more rapid spread of a phage population in vivo with 
faster access to an STEC and/or EHEC host attached to 
the bovine intestinal mucosa (Moxley 2004; Abedon and 
Culler 2007b). The plaque sizes and halo formations of 
the phages against their respective 0157:147 isolation 
host were analysed in TS, LB and N soft agars with and 
without the addition of 10 mmol I-1 CaCl2. Table 5 
shows the mean plaque sizes obtained for every phage 
on each medium, and significantly larger (P < 0 05) 
plaque sizes among those of phages isolated from the 
same host are highlighted in bold in the table. The non- 
0157 phages CCO103, CCO113, CBO103 and CBO113 
and the 0157 phage CB60P are omitted in this table, 
because these phages formed only pinpoint plaques in all 
media. No differences in plaque sizes or morphologies 
were observed with the addition of CaCl2. Statistical 
analysis of the plaque sizes indicated that the phages 
MFA60D and CB60I4 both attained significantly higher 
mean plaque sizes (P < 0 05) than did MFA60N against 
strain 69160 in each of the three media. Among the 
phages tested against strain 933, phage CA933P had sig­
nificantly larger plaques than all the other phages of the 
group in TS medium; whereas phages MFA933I4 and 
MFA933P, isolated from faecal samples, had plaque sizes 
significantly higher than the phages isolated from meat 
in LB medium. As phage CA911 was the only one 
isolated with strain 68911 as host, this phage was not 
compared with any other.
Plaques were also analysed for the appearance of a halo - 
the clear zone surrounding plaques caused by the diffusion
Table 5 Mean plaque size in different media
Phage Strain
Plaque size (mm)
N TS LB
CA911 68911 4-1* 3-9 3-5
MFA45N 71945 4-7* 3-5 3-8f
MFA45D 5-0* 2-9* 3-4f
MFA60D 69160 4.9* 40 46
MFA60N 2-4f 2-4 3-0
CB60H 4-6* 41 48
MFA933H 933 4-5* 4-3f 42
MFA933P 4-6* 4-11 41
CA933N 4-7* 4-3f 37
CA933P 4-8* 5-8f 3 1
CA933D 5-5* 4-8f 3-6
Significantly larger mean plaque sizes (P < 0-05) among those 
obtained with the same bacterial host are highlighted in bold.
*Great increase in halo diameter after 72 h.
■(■Moderate halo growth after 72 h.
Figure 3 Plaques of phage CA933N in TS agar and N agar before 
and after 72 h at room temperature. TS show a moderate increase on 
halo size and N a great halo growth after 72 h (as described in 
Table 5). Each pair of 'before and after’ quadrants is mirror image of 
the same agar plate.
of phage depolymerases that decapsulate bacteria to 
leave a translucent ring over the opaque bacterial lawn 
(Bessler et al. 1975; Kwiatkowski et al. 1982; Tomlinson 
and Taylor 1985; Hughes et al. 1998). Halo formation 
could be a desirable characteristic for phages chosen as 
biocontrol agents of STEC and EHEC, as the bacterial 
capsule is known to be a contributor to virulence in E. coli 
(Russo 2002).
All phages formed halos in N agar that greatly 
increased in size after 72 h at room temperature 
(Fig. 3), except for MFA60N, whose halo grew notably 
less. In TS agar, however, the plaques on the 933 host 
showed only a moderate increase in halo diameter 
(Fig. 3), with only those of phage MFA45D manifesting 
a similar substantial halo growth to that observed in N 
broth. In contrast, only phages from strain 71945 
formed haloes with moderate increases in size in LB 
medium.
Acidity resistance
Phages selected for oral application in cattle must be able 
to resist the highly acidic gastric passage so as to enter 
the bovine intestine at a high enough concentration to be 
effective. To test for acid resistance, the phages were 
exposed to pH values ranging from 7 to 1 and titrated 
after a 16-h incubation at 37°C.
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After incubation at pHs from 7 to 5, all phages 
conserved the same titres as the controls. At pH 4 the 
greatest difference in survival occurred among the phages, 
with the titres falling by 3-5 orders of magnitude. No 
viable particles were detected at pH 3 or lower. The phage 
CA911 had a titre decay of 31 orders of magnitude at 
pH 4 - a falling-off of viability equivalent to that seen 
with phages MFA933P, CA933N and MFA45D, but 
significantly lower (P < 0 05) than that observed for all 
the other phages. No significant difference in survival was 
observed among the phages of 71945, with titre drop-offs 
of 3 4 and 3 9 orders of magnitude. The three phages iso­
lated from strain 69160 were the least resistant to acidity, 
with titre losses from 4 to 5 3 orders of magnitude at pH 
4; though, among them the isolate MFA60D proved 
significantly more resistant (P < 0 05) at this pH than the 
other two.
Discussion
In this study, 20 STEC and EHEC bacteriophages were 
isolated from pork sausage, minced meat, and bovine 
faecal samples. As meat contamination with E. coli mainly 
derives from its contact with a ruminant’s intestinal 
faeces during slaughter (Elder et al. 2000), ground beef 
and bovine stools were chosen as sources of phages whose 
natural environment was already the ruminant’s gut, as 
these phages would be expected to survive in the bovine 
intestine better than those from other environments. This 
is the first report of the isolation and characterization of 
STEC and EHEC phages in Argentina.
To initially screen possible candidates for phage ther­
apy in calves, phages able to infect nonpathogenic E. coli 
were discarded for further characterization because such 
phages could cause an imbalance in the bovine intestinal 
flora (Tanji et al. 2005). Phages of that type, however, 
might be considered as good candidates for other applica­
tions - e.g., biocides for sanitary surfaces and even for 
food (Kudva et al. 1999; O’Flynn et al. 2004) or antibiotic 
agents in the treatment of superficial or other infections 
(O’Flaherty et al. 2009), where a disturbance to other 
related micro-organisms is irrelevant. This left 16 possible 
calf phage therapy candidates from two different 
morphologic families within the order Caudovirales: 10 
belonged to the Podoviridae family morphotype Cl, all of 
them isolated from O157:H7 hosts; while the remaining 
six pertained to the Myoviridae family morphotype Al, 
with two isolated from a O157:H7 host and the other 
four from hosts with serotypes O103:H2 and O113:H21.
Molecular characterization of the selected phages was 
performed by amplification profiles of their genomes by 
RAPD and rep-PCR and by detection of the stxl, stx2, 
and cl genes by PCR. The profiles obtained by RAPD 
with primers RAPD6 and RAPD 10 were similar in band 
number and differentiation power to those obtained by 
rep-PCR, but a better differentiation was obtained with 
primer RAPD9, which sequence yielded profiles with a 
higher number of bands and was the only one that 
allowed some differentiation among the phages isolated 
from strain 933, those all being 0157 phages with the 
same microscopic morphology. As previously reported, 
RAPD proved to be a simple and highly reproducible 
technique for differentiation among phages specific to a 
particular bacterial host (Perez et al. 1998; Barrangou 
et al. 2002; Shivu et al. 2007) and thus constitutes a facile 
approach to the analysis of phage DNA, especially when 
working with large numbers of samples. This work repre­
sents the first time that rep-PCR has been used for the 
characterization of phages as a complement to RAPD 
profiles. The RAPD and rep-PCR results together allowed 
a marked differentiation among the phages because the 
relationships among the different isolates were established 
comparing both the profiles obtained with different 
primers and those resulting from different amplification 
methods. RAPD and rep-PCR profiles from non-O157 
Myoviridae phages were, as expected, completely different 
from those from Podoviridae phages because isolates 
from those two phage families differed not only in their 
morphology but also in their host ranges. For obtaining 
consistent results on the PCR profiles - in terms of 
amplification fragment size and number and the relative 
intensity of bands - all the experimental conditions were 
maintained throughout the different experiments and 
involved DNA template concentrations that were stan­
dardized to ensure that the patterns obtained from differ­
ent phages could be compared to each other.
PCR amplification of the stx and cl genes revealed that 
all the phages positive for stxl and/or cl were non-O157 
phages and belonged to the Myoviridae family, and those 
positive for stx2 were one Myoviridae and two Podoviri­
dae 0157 phages, all three isolated from the same bacte­
rial host. Short-tailed and long rigid-tailed phages have 
been previously reported as carriers of stxl or stx2 genes 
(Willshaw et al. 1987; Muniesa et al. 2000; Allison et al. 
2003; Muniesa et al. 2003a, 2004a,b; Garcia-Aljaro et al. 
2006).
All phages positive for either stx or cl are contra­
indicated for any type of phage therapy, as they represent 
a hazard of possible horizontal transfer of genes (Brussow 
2005; Kropinski 2006; Parisien et al. 2008).
In this work, PCR determinations under conditions 
specific for stxl, stx2 and cl were used to screen for unde­
sirable genes. Nevertheless, because PCR results are not 
an absolute proof of the presence or absence of a given 
gene, the total sequencing of the genomes of any candi­
dates for use in phage therapy must necessarily be the 
© 2010 The Authors
Journal compilation © 2010 The Society for Applied Microbiology, Journal of Applied Microbiology 109 (2010) 873-887882
C. Dini and P.J. de Urraza Selection of coliphages as biocontrol agents
last obligatory step before the latter’s implementation 
(Brussow 2005; O’Flaherty et al. 2009).
Isolated phages were furthermore characterized by their 
plaque size and halo formation on their respective isola­
tion host in different culture media. As plaque size in soft 
agar could be considered an approximation of phage 
proliferation and spread in natural matrices (such as an 
animal’s intestinal mucosa) where bacterial hosts grow 
within a structured environment (Abedon and Yin 2008), 
phages with extensive plaque formation were chosen as 
the most promising candidates for phage therapy in 
cattle.
The Myoviridae phages, excepting CA911, formed pin­
point plaques in all media assayed. These kinds of plaques 
could either result from long latent periods, very small 
burst sizes, and/or a low rate of adsorption of phage 
particles onto the host bacterium (Abedon and Yin 2008) 
or indicate an association with the temperate phage 
phenotype. This last possibility agrees with the observa­
tion that, when spotted on bacterial lawns of almost all 
of their hosts, those phages formed lysis zones with a 
high turbidity (Guttman et al. 2005), and four of them 
tested positive for stx and/or cl. Whatever the reason 
might be, any or all of those characteristics would ren­
der them undesirable as phages for use as therapeutic 
agents. They were accordingly excluded from further 
characterization.
The remaining phages formed well-defined plaques, in 
some instances, surrounded with a halo. The presence of 
halos has been described as the result of the diffusion of 
phage depolymerases that degrade capsule exopolysaccha­
rides (Bessler et al. 1975; Tomlinson and Taylor 1985; 
Hughes et al. 1998). Depolymerase activity of phages - 
along with infection and lysis - could be considered an 
additional mechanism against pathogens as the bacterial 
capsule itself in E. coll is considered to be a virulence 
factor (Russo 2002) through protecting the bacterium 
from the animal or human host’s immunologic defences 
and has also been reported to enhance the attachment of 
this particular bacterial pathogen to a given surface 
(Hassan and Frank 2004; Sharma et al. 2005). Haloes 
from the same phage on the same host did not have the 
same size among the three different media, probably as a 
result of the different growth states of the bacteria. Bigger 
halos were observed in N agar than in TS agar for almost 
all the isolated phages assayed, despite the results of 
Hassan and Frank (2004), who reported no capsule 
production of O157:H7 in N broth. A possible explana­
tion for this discrepancy is that the capsule formed with 
bacteria growing in N agar can be thinner than that 
observed in TS agar, and thus the former appears as a 
more extensive depolymerase activity in the agar plate, 
whereas such a thin capsule formed in N broth may have 
not been detected by light microscopy, as discussed by 
those same authors. Another characteristic sought in 
phages to be used for therapy is a broad host range for 
the target bacteria. Therefore, among the phages with 
extensive plaque formation, those able to infect as many 
serotypes as possible should be chosen to obtain a 
cocktail of phages that infect the widest possible range of 
serotypes with the lowest number of phages. Phages able 
to infect genera other than E. coll could be useful in that 
they would eliminate other pathogens as well, but the 
possibility of infection of other bacteria not contemplated 
in the host range assays should be taken into consider­
ation. Of all the other Gram-negative pathogens tested, 
apart from Shigella, only Ps. aeruginosa was infected and 
was likewise sensitive to many of the isolated phages from 
both the Myoviridae and the Podoviridae families. Phages 
capable of infecting both Ps. aeruginosa and E. coli have 
been previously reported (Jensen et al. 1998).
The final characteristic analysed was the acid resistance 
of the phages exhibiting extensive plaque formation since 
phages selected for oral administration to bovines must 
resist gastric passage and reach the intestine at a sufficient 
concentration to target a pathogen (Koo et al. 2000; 
Chibani-Chennoufi et al. 2004). To do so, those phages 
must accordingly withstand acidity levels of c. pH 1. With 
respect to comparative acidity resistance, in agreement 
with the results obtained in a previous report (Jamallu- 
deen et al. 2007), all the phages tested here were acid 
resistant down to a pH of 5, but then different resistances 
were observed at pH 4, with titre losses from 103 to 
105 UFP ml-1 occurring after 16 h. As no phage particles 
were detected at pH 3 or lower, for oral administration 
phages would have to be included in an acid-resistant 
matrix for protection to serve as a vehicle for phage 
delivery. In this regard administration with bicarbonate, 
as other delivery strategy, has been previously proposed 
(Chibani-Chennoufi et al. 2004; Tanji et al. 2005). Even 
under such conditions phages able to tolerate the lowest 
possible pHs would nevertheless be desirable to use. 
Alternatively, such acid-resistant phages could be applied 
as biocides in combination with other acidic treatment 
agents (Choi et al. 2009; Gill 2009; Laury et al. 2009) or 
might be suitable for the decontamination of acidic 
foods.
In summary, 16 of the original 20 phages isolated failed 
to infect the nonpathogenic E. coli strains assayed; and as 
determined by screening for the stxl, stx2, and cl genes, 
only 10 amplified neither stx nor cL One of the isolates 
negative for stx and cl was a non-O157 myophage, but 
was discarded as a possible biocontrol agent out of pre­
caution because of its similarity in plaque morphology 
plus its RAPD and rep-PCR profiles to the other three 
non-O157 myophages isolated that were in fact positive 
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for amplification of either of those two genes. Of the nine 
remaining phages negative for both stx and for cl, one 
was from the Myoviridae and eight from the Podoviridae 
families; and all nine produced well-defined plaques. The 
widest host ranges were obtained with myophage CA911 
and podophage CA933P, although the latter was not 
specific to STEC and EHEC. CA911, for its part, was one 
of the phages with the highest acid resistance with a titre 
loss of 315 orders of magnitude at pEI 4, MFA933P and 
CA933N exhibited a similar pEI resistance to that of 
CA911, and one significantly higher than those of the 
other 933 phages; but MFA933P also had significantly lar­
ger plaques in LB agar than did CA933N. Phage MFA45D 
likewise had a high acidity resistance and moreover was 
the only phage isolated that showed depolymerase activity 
in all three media assayed.
Phages chosen for a therapeutic cocktail should have 
infection mechanisms as different as possible so that, if 
some of the targeted pathogens become resistant to one 
of those phages, it will still remain sensitive to the others 
- a possibility that might be reflected initially by a diver­
sity in their genomic profiles. A high similarity between 
the RAPD and rep-PCR profiles was observed for the 
phages from 933, so phage CA933N was discarded as it 
did not have the highest acidity resistance nor the bigger 
plaques size among 933 phages. Out of this selection, the 
isolated phages CA911, CA933P, MFA933P and MF45D 
would appear to be the best candidates for oral adminis­
tration as therapeutic agents in cattle. It should be high­
lighted that, as Podoviridae phages infecting STEC and 
EHEC are rarely described, they have never been 
proposed as biocontrol agents of these bacteria. Neverthe­
less, we found members of this family whose characteris­
tics make them promising candidates as biocontrol agents 
of STEC and EHEC.
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